Selye Janos Korhaz
About Selye Janos Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Boehringer Ingelheim
3
Amgen
2
Artu Biologicals
2
Arrowhead Pharmaceuticals
1
Daiichi Sankyo, Inc.
1
Eli Lilly and Company
1
Ionis Pharmaceuticals, Inc.
1
Kowa Research Institute, Inc.
1
Resverlogix Corp
1
Clinical Trials at Selye Janos Korhaz
During the past decade, Selye Janos Korhaz conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on
average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
2006-12-01
2008-03-01
Completed
605
Long-term Efficacy and Safety Study With Oralgen Grass Pollen
2007-08-01
2009-01-01
Completed
356
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Selye Janos Korhaz" #1 sponsor was "Bayer" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Amgen" with 2 trials sponsored, "Artu Biologicals" with 2 trials sponsored and "Arrowhead Pharmaceuticals"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Selye Janos Korhaz"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Selye Janos Korhaz
According to Clinical.Site data, the most researched conditions in "Selye Janos Korhaz" are
"Allergic Rhinoconjunctivitis" (2 trials), "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Selye Janos Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Selye Janos Korhaz
Most popular intervention types in "Selye Janos Korhaz" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (2 trials), "Oralgen" (2 trials), "ARO-APOC3" (1 trials) and "Apabetalone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Selye Janos Korhaz
The vast majority of trials in "Selye Janos Korhaz" are
14 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Selye Janos Korhaz
Currently, there are NaN active trials in "Selye Janos Korhaz".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Selye Janos Korhaz,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Selye Janos Korhaz, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".